🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Some breast cancer cells make a protein called Human Epidermal Growth facto...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-11-06
Trial ID
NCT02286843
Treatments Being Tested
This is an open-label, single center, pilot study to assess the feasibility...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-31
Trial ID
NCT04757090
Treatments Being Tested
ZEPHIR-02 is a multicentre, open-label phase II study that will enroll subj...
Status
Terminated
Location
Institut Jules Bordet
Start Date
2026-06-30
Trial ID
NCT06595563
Treatments Being Tested
The purpose of the first group (Group 1) was to find the optimal time for t...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-12
Trial ID
NCT02023996
Treatments Being Tested
The investigators investigate whether PET imaging with ⁸⁹Zr-trastuzumab can...
Status
Not Yet Recruiting
Location
The Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2026-09-07
Trial ID
NCT07436858
Treatments Being Tested
T-DM1 , which is a highly innovative but also expensive antiHER2 agent cons...
Status
Completed
Location
Universitair Ziekenhuis Antwerpen (UZA)
Start Date
2012-05
Trial ID
NCT01565200
Treatments Being Tested
Evaluation of the diagnostic potential of HER2 imaging using zirconium 89 l...
Status
Completed
Location
Jules Bordet Institut
Start Date
2011-08
Trial ID
NCT01420146
Treatments Being Tested
The main purpose of this study is to see if Positron Emission Tomography (P...
Status
Completed
Location
Washington University School of Medicine @ Barnes-Jewish Hospital
Start Date
2014-02
Trial ID
NCT02065609
Treatments Being Tested
The goal of this clinical trial is to test a new PET tracer in patients wit...
Status
Completed
Location
AmsterdamUMC
Start Date
2023-06-26
Trial ID
NCT05955833
Treatments Being Tested
Our goal is to investigate the use of 89Zr-trastuzumab as a HER2 imaging ag...
Status
Recruiting
Location
The Kirklin Clinic
Start Date
2017-11-21
Trial ID
NCT03321045
Treatments Being Tested